Iwona Kurkowska‐Jastrzębska

Author

Institute of Psychiatry and Neurology ORCID

Also Known As

Anna Baranowska, I Kurkowska-Jastrzebska, I. Kurkowska-Jastrzebska, I. Kurkowska-Jastrzębska, I. Kurkowska-Jastrzȩbska, I. Kurkowska‐Jastrzebska, Iwona Jastrzebska-Kurkowska, Iwona Jastrzebska‐Kurkowska, Iwona Kurkowska-Jastrz?bska, Iwona Kurkowska-Jastrzebska

190

Publications

4.2K

Citations

H-Index

Concepts

All Affiliations

Institute of Psychiatry and Neurology Medical University of Warsaw Medical University of Lublin Poznan University of Medical Sciences University Hospital Carl Gustav Carus

About

Iwona Kurkowska‐Jastrzębska is an author at Institute of Psychiatry and Neurology specializing in medicine, neuroscience, and neurology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	27	1.8K
2	Public Health	3	3	84
3	Social Sciences	3	3	78
4	Health Sciences	1	1	20
5	Allergy	1	1	16

Iwona Kurkowska‐Jastrzębska

Publications

2.8K

Citations

H-Index

Page 1

	Year	Citations
The Inflammatory Reaction Following 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Intoxication in Mouse Iwona Kurkowska‐Jastrzębska, Aneta Wrońska, Małgorzata Kohutnicka, Experimental Neurology InflammationAnti-inflammatoryInflammatory ReactionMedicineForensic Toxicology	1999	374
Microglial and astrocytic involvement in a murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Małgorzata Kohutnicka, Eliza Lewandowska, Iwona Kurkowska‐Jastrzębska, Immunopharmacology Astrocytic InvolvementMedicineMurine ModelPharmacologyBrain-immune Interaction	1998	284
Microglial Reaction in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) Induced Parkinson's Disease Mice Model Anna Członkowska, Małgorzata Kohutnicka, Iwona Kurkowska‐Jastrzębska, Neurodegeneration MedicinePharmacologyNeuropharmacologyBrain-immune InteractionNeuroprotection	1996	280
Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial Scott E. Kasner, Balakumar Swaminathan, Pablo M. Lavados, The Lancet Neurology	2018	177
Immune processes in the pathogenesis of Parkinson's disease - a potential role for microglia and nitric oxide. Anna Członkowska, Iwona Kurkowska‐Jastrzębska, Andrzej Członkowski, PubMed Nitric OxideImmunologyCell DeathImmune SystemNeuroinflammation	2002	123
MHC class II positive microglia and lymphocytic infiltration are present in the substantia nigra and striatum in mouse model of Parkinson's disease Iwona Kurkowska‐Jastrzębska, Aneta Wrońska, Małgorzata Kohutnicka, Acta Neurobiologiae Experimentalis	1999	120
Dexamethasone protects against dopaminergic neurons damage in a mouse model of Parkinson's disease Iwona Kurkowska‐Jastrzębska, Tomasz Litwin, Ilona Joniec‐Maciejak, International Immunopharmacology Dexamethasone ProtectsMedicineNeuropharmacologyNeuroprotectionNeuroscience	2004	117
Indomethacin protects against neurodegeneration caused by MPTP intoxication in mice Iwona Kurkowska‐Jastrzębska, M. Babiuch, Adam Przybyłkowski, International Immunopharmacology Neurodegenerative DiseasesNeuropeptidesMedicinePharmacologyMptp Intoxication	2002	79
Age- and sex-differences in the nitric oxide synthase expression and dopamine concentration in the murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Ilona Joniec‐Maciejak, Agnieszka Ciesielska, Iwona Kurkowska‐Jastrzębska, Brain Research MedicineParkinson DiseaseDopamine ConcentrationMurine ModelNeuropharmacology	2009	71
Semiquantitative Scale for Assessing Brain MRI Abnormalities in Wilson Disease: A Validation Study Petr Dušek, Łukasz Smoliński, Barbara Rędzia-Ogrodnik, Movement Disorders	2020	63

Page 1